GMAB
Genmab A/S
There isn't enough reported data to score GMAB yet.
GMAB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
GMAB's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
GMAB PE Valuation
GMAB has no meaningful PE right now: it lost money over the past year.
GMAB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GMAB, but weaker profitability. However, they disagree widely on these estimates.
GMAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $12.16 | +85% |
| Q2 2024 | $6.59 | -12% |
| Q1 2024 | $6.85 | -9.9% |
| Q4 2023 | $6.59 | -14% |
| Q2 2023 | $7.48 | +81% |
| Q1 2023 | $7.60 | +101% |
| Q4 2022 | $7.66 | +95% |
| Q2 2022 | $4.14 | +48% |
GMAB earned $12.16 per share over the past year, up 63% from the year before.
GMAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $2.1B | +17% |
| Q4 2024 | $1.8B | +27% |
| Q2 2024 | $115.8M | -81% |
| Q1 2024 | $89.6M | -79% |
| Q4 2023 | $1.4B | +1.2% |
| Q2 2023 | $619.6M | +32% |
| Q1 2023 | $421.2M | +34% |
| Q4 2022 | $1.4B | +89% |
GMAB's revenue is growing: $2.1B last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 25% | -11 points |
| Q4 2024 | 36% | +0.4 points |
| Q2 2024 | 30% | +16 points |
| Q1 2024 | 19% | -30 points |
| Q4 2023 | 36% | -3.5 points |
| Q2 2023 | 35% | +11 points |
| Q1 2023 | 15% | -20 points |
| Q4 2022 | 49% | +9.4 points |
GMAB's operating margin was 25% last quarter, down 11 points from the same quarter a year ago.
GMAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $822M | +20% |
| Q4 2024 | $685.5M | +30% |
| Q2 2024 | $32M | -37% |
| Q1 2024 | $32M | -93% |
| Q4 2023 | $526.7M | +63% |
| Q2 2023 | $50.4M | -62% |
| Q1 2023 | $465.3M | +491% |
| Q4 2022 | $323.1M | +300% |
GMAB generated $1.6B in free cash flow over the past year, up 15% from the year before.
GMAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -7.7M shares |
| 1 year | -1.7% | -10.9M shares |
| 3 years | +4.5% | +27.9M shares |
| 5 years | +4.8% | +30M shares |
GMAB has 649M diluted shares, down 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | — |
| Q2 2024 | $65.1M |
| Q1 2024 | $11.7M |
| Q4 2023 | — |
| Q2 2023 | $5.2M |
| Q1 2023 | $92.4M |
| Q4 2022 | $94.8M |
GMAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2019 | -0.4x | Net Cash |
| Q1 2019 | -0.9x | Net Cash |
| Q4 2018 | -0.4x | Net Cash |
| Q3 2018 | -0.6x | Net Cash |
| Q2 2018 | -0.9x | Net Cash |
| Q1 2018 | -0.6x | Net Cash |
| Q4 2017 | -1.0x | Net Cash |
| Q3 2017 | -0.8x | Net Cash |
GMAB has more cash than debt.
GMAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.6 | Overbought |
| Stochastic | 81.0 | Overbought |
GMAB's weekly RSI is 76 (overbought) and its Stochastic is 81 (overbought).
GMAB PE vs Healthcare Sector
| Metric | GMAB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
GMAB has no meaningful PE right now: it lost money over the past year.
GMAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.8 | 18% above |
| 20 week MA | $36.3 | 43% above |
| 50 week MA | $31.8 | 63% above |
| 100 week MA | $27.7 | 87% above |
| 200 week MA | $29.7 | 74% above |
GMAB has climbed back above all five of its weekly moving averages, and it's now 74% above its 200-week average.
GMAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.3 | $39.1 | +76% |
| 2021 | $39.1 | $39.7 | +1.5% |
| 2022 | $39.7 | $43.1 | +8.5% |
| 2023 | $43.1 | $31.8 | -26% |
| 2024 | $31.8 | $21.0 | -34% |
| 2025 | $21.0 | $33.4 | +59% |
| 2026 YTD | $33.4 | $51.7 | +55% |
GMAB has finished higher in four of the last six years, two of them by more than 50%. It's up 55% so far in 2026.